A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
暂无分享,去创建一个
P. Vermersch | G. Comi | G. Giovannoni | P. Chang | P. Rieckmann | S. Cook | P. Soelberg Sørensen | S. Greenberg | K. Rammohan | B. Musch | A. Hamlett
[1] L. Aagaard,et al. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity , 2009, Retrovirology.
[2] B. Kieseier,et al. Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis , 2009, European journal of neurology.
[3] P. Rieckmann,et al. Emerging oral therapies for multiple sclerosis , 2007, International journal of clinical practice.
[4] T. Chitnis. The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis , 2007, International Review of Neurobiology.
[5] H. Wiendl,et al. Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006. , 2007, Endocrine, metabolic & immune disorders drug targets.
[6] Z. Stelmasiak,et al. Interleukin‐8 and RANTES levels in patients with relapsing–remitting multiple sclerosis (RR‐MS) treated with cladribine , 2004, Acta neurologica Scandinavica.
[7] P. Mehta,et al. Effect of cladribine treatment on beta-2 microglobulin and soluble intercellular adhesion molecule 1 (ICAM-1) in patients with multiple sclerosis. , 2001, Folia morphologica.
[8] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[9] M Filippi,et al. Cladribine and progressive MS , 2000, Neurology.
[10] F. Barkhof,et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis , 1999, Neurology.
[11] J. Koziol,et al. The treatment of chronic progressive multiple sclerosis with cladribine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Koziol,et al. Cladribine in treatment of chronic progressive multiple sclerosis , 1994, The Lancet.
[13] G. McBride. Patients with multiple sclerosis enter lottery. , 1993, BMJ.
[14] E. Beutler. Cladribine (2-chlorodeoxyadenosine) , 1992, The Lancet.
[15] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[16] A. Wajgt,et al. Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis. , 2001, Medical science monitor : international medical journal of experimental and clinical research.
[17] J. Koziol,et al. A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis. , 1999, Proceedings of the Association of American Physicians.
[18] J. Koziol,et al. A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis. , 1999, Proceedings of the Association of American Physicians.